Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia

Archives of Disease in Childhood

Volumn 88, Issue 2, 2003, Pages 158-159

  Rahman, M A S ^a   Birrell, G ^d   Stewart, H ^b   Lucraft, H ^c   Cheetham, T D ^d  

^a HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH DURHAM   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; PROPYLTHIOURACIL; THYROXINE;

ARTICLE; CASE REPORT; CHILD; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MITRAL VALVE PROLAPSE; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; THYROTOXICOSIS;

ANTITHYROID AGENTS; CARBIMAZOLE; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MITRAL VALVE PROLAPSE; NEUTROPENIA; PROPYLTHIOURACIL; THYROTOXICOSIS;

EID: 0037308958     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.2.158     Document Type: Article

References (11)

1. Cheetham TD, Hughes IA, Barnes ND, et al. Treatment of hyperthyroidism in young people. Arch Dis Child 1998;78:207-9.
2. Shulman DI, Muhar I, Jorgensen EV, et al. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997;7:755-60.
3. Perrild H, Gruters-Kieslich A, Feldt-Rasmussen U, et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. Eur J Endocrinol 1994;131:467-73.
4. Rivkees AS, Sklar C, Freemark M. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767-74.
5. The Radioiodine Audit Subcommittee of the Royal College of Physicians Committee on Diabetes and Endocrinology, and The Research Unit of the Royal College of Physicians. The use of radioiodine in the management of hyperthyroidism. London: Royal College of Physicians of London, November 1995.
6. Dobyns BM, Sheline GE, Workman JB, et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 1974;38:976-8.
7. Nikiforov Y, Gnepp DR, Fagin JA. Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiatian tumorigenesis. J Clin Endocrinol Metab 1996;81:9-14.
8. Channick BJ, Adlin EV, Marks AD, et al. Hyperthyroidism and mitral-valve prolapse. N Engl J Med 1981;305:497-500.
9. Cavallo A, Joseph CJ, Casta A. Cardiac complications in juvenile hyperthyroidism. Am J Dis Child 1984;138:479-82.
10. Evangelopoulou ME, Alevizaki M, Toumanidis S, et al. Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity? Thyroid 1999;9:973-7.
11. Khoo DH, Parma J, Rajasoorya C, et al. A germ line mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family. J Clin Endocrinol Metab 1999;84:1459-62.